The epidemiology and iatrogenic transmission of hepatitis C virus in egypt: A Bayesian coalescent approach

Molecular Biology and Evolution

Volumn 20, Issue 3, 2003, Pages 381-387

  Pybus, O G ^a   Drummond, A J ^b   Nakano, T ^c   Robertson, B H ^c   Rambaut, A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c Centers for Dis Ctrl/Prevention   (United States)

Author keywords

Bayesian inference; Egypt; Epidemiology; Hepatitis C

Indexed keywords

ARTICLE; BAYES THEOREM; DEMOGRAPHY; EGYPT; EPIDEMIC; EPIDEMIOLOGICAL DATA; GROWTH; HEPATITIS C; HEPATITIS C VIRUS; LIVER CANCER; LIVER CIRRHOSIS; POPULATION GENETIC PARAMETERS; PREVALENCE; QUANTITATIVE GENETICS; STATISTICAL ANALYSIS; VIRUS TRANSMISSION;

BAYES THEOREM; DEMOGRAPHY; EGYPT; HEPACIVIRUS; HEPATITIS C; HUMANS; IATROGENIC DISEASE; MODELS, GENETIC; MUTAGENESIS; PREVALENCE;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0037358963     PISSN: 07374038     EISSN: None     Source Type: Journal    
DOI: 10.1093/molbev/msg043     Document Type: Article

References (41)

1. Anderson, R. M., and R. M. May. 1991. Infectious diseases of humans: dynamics and control. Oxford University Press.
2. Angelico, M., E. Renganathan, C. G. Gandin et al. (14 co-authors). 1997. Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J. Hepatol. 26:236-243.
3. Arthur, R. R., N. F. Hassan, M. Y. Abdallah, M. S. El Sharkawy, M. D. Saad, B. G. Hackbart, and I. Z. Imam. 1997. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans. R. Soc. Trop. Med. Hyg. 91:271-274.
4. Centers for Disease Control and Prevention. 1998. Morbidity and Mortality Weekly Report 47:No. RR-19.
5. Drummond, A. J., G. K. Nicholls, A. G. Rodrigo, and W. Solomon. 2002. Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data. Genetics 161:1307-1320.
6. El-Zayadi, A., H. Abaza, S. Shawky, M. K. Mohamed, O. Selim, and H. M. Badran. 2001. Prevalence and epidemiological features of hepatocellular carcinoma in Egypt - a single centre experience. Hepatol. Res. 19:170-179.
7. El-Zayadi, A., O. Selim, S. Haddad, P. Simmonds, H. Hamdy, H. M. Badran, and S. Shawky. 1999. Combination treatment of interferon α-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients. Ital. J. Gastroenterol. Hepatol. 31:472-475.
8. El-Zayadi, A., P., Simmonds, H. Dabbous, L. Prescott, O. Selim, and A. Ahdy. 1996. Response to interferon-α of Egyptian patients infected with hepatitis C virus genotype 4. J. Viral Hepatitis 3:261-264.
9. Felsenstein, J. 1981. Evolutionary trees from DNA sequences: a maximum likelihood approach. J. Mol. Evol. 17:368-376.
10. Frank, C., M. K. Mohamed, G. T. Strickland et al. (12 co-authors). 2000. The role of parenteral antischistosomal therapy in the spread of hepatitis C in Egypt. Lancet 355:887-891.
11. Gad, A., E. Tanaka, K. Orii, A. Rokuhara, Z. Nooman, A. H. Serwah, M. Shoair, K. Yoshizawa, and K. Kiyosawa. 2001. Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect. J. Gastroenterol. 36:753-758.
12. Grassly, N. C., P. H. Harvey, and E. C. Holmes. 1999. Population dynamics of HIV-1 inferred from gene sequences. Genetics 151:427-438.
13. Griffiths, R. C., and S. Tavaré.1994. Sampling theory for neutral alleles in a varying environment. Phil. Trans. R. Soc. Lond. Ser. B. 344:403-410.
14. Habib, M., M. K. Mohamed, F. Abdel-Aziz, L. S. Magder et al. (12 co-authors) 2001. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 33:248-253.
15. Hassan, M. M., A. S. Zaghloul, H. B. El-Serag, O. Soliman, Y. Z. Patt, C. L. Chappell, R. P. Beasley, L. Y. Hwang. 2001. The role of hepatitis C in hepatocellular carcinoma - a case control study among Egyptian patients. J. Clin. Gastroenterol. 33:123-126.
16. Kalinina, O., H. Norder, S. Mukomolov, and L. O. Magnius. 2002. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J. Virol. 76:4034-4043.
17. Kamal, S. M., M. A. Madwar, T. Peters, R. Fawzy, and J. Rasenack. 2000. Interferon therapy in patients with chronic hepatitis C and schistosomiasis. J. Hepatol. 32:172-174.
18. Kao, J. H., and D. S. Chen. 2000. Transmission of hepatitis C virus in Asia: past and present perspectives. J. Gastroenterol. Hepatol. 15:E91-E96.
19. Kingman, J. F. C. 1982. On the genealogy of large populations. J. Appl. Prob. 19A:27-43.
20. Kuhner, M. K., J. Yamato, and J. Felsenstein. 1998. Maximum likelihood estimation of population growth rates based on the coalescent. Genetics 149:429-434.
21. Lande, R. 1998. Demographic stochasticity and Allee effect on a scale with isotropic noise. Oikos 83:353-358.
22. Maegraith, B. G. 1964. Treatment of bilharziasis in Egypt, UAR. World Health Organization, Geneva.
23. May, R. M., S. Gupta, and A. R. McLean. 2001. Infectious disease dynamics: what characterises a successful invader? Phil. Trans. R. Soc. Lond. Ser. B. 356:901-910.
24. McCarthy, M. C., A. El Tigani, I. O. Khalid, and K. C. Hyams. 1994. Hepatitis B and C in Juba, southern Sudan: results of a serosurvey. Trans. Roy. Soc. Trop. Med. Hyg. 88:534-536.
25. Nafeh, M. A., A. Medhat, M. Shehata, N. N. Mikhail, Y. Swifee, M. Abdel-Hamid, S. Watts, A. D. Fix, G. T. Strickland, W. Anwar, and I. Sallam. 2000. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Am. J. Trop. Med. Hyg. 63:236-241.
26. Posada, D., and K. A. Crandall. 1998. Modeltest: testing the model of DNA substitution. Bioinformatics 14:817-818.
27. Pybus, O. G., M. A. Charleston, S. Gupta, A. Rambaut, E. C. Holmes, and P. H. Harvey. 2001. The epidemic behaviour of the hepatitis C virus. Science 292:2323-2325.
28. Pybus, O. G., A. Rambaut, and P. H. Harvey. 2000. An integrated framework for the inference of viral population history. Genetics 155:1429-1437.
29. Quinti, I., E. Renganathan, E. El Ghazzawi, M. Divizia, G. Sawaf, S. Awad, A. Pana, and G. Rocchi. 1995. Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralbl. Bakteriol. 283:239-244.
30. Rambaut, A. 2000. Estimating the rate of molecular evolution: incorporating non-contemporaneous sequences into maximum likelihood phylogenies. Bioinformatics 16:395-399.
31. Ray, S. C., R. R. Arthur, A. Carella, J. Bukh, and D. L. Thomas. 2000. Genetic epidemiology of hepatitis C virus throughout Egypt. J. Infect. Dis. 182:698-707.
32. Rodrigo, A. G., E. G. Shpaer, E. L. Delwart, A. K. Iversen, M. V. Gallo, J. Brojatsch, M. S. Hirsch, B. D. Walker, and J. I. Mullins. 1999. Coalescent estimates of HIV-1 generation time in vivo. Proc. Natl. Acad. Sci. USA 96:2187-2191.
33. Salemi, M., and A. M. Vandamme. 2002. Hepatitis C virus evolutionary patterns studied through analysis of full genome sequences. J. Mol. Evol. 54:62-70.
34. Schierup, M. H., and J. Hein. 2000. Consequences of recombination on traditional phylogenetic analysis. Genetics 156:879-879.
35. Shobokshi, O., E. Serebour, L. Skakni et al. 2002. Peg-IFN α-2a as a monotherapy or in combination with ribavirin significantly improves end of treatment response rate in HCV genotype 4 chronic active hepatitis patients. Abstract. 2002 Meeting of the American Association for the Study of Liver Disease.
36. Shobokshi, O., E. Serebour, L. Skakni, Y. Al Saffy, and M. Ahdal. 1999. Hepatitis C genotypes and subtypes in Saudi Arabia. J. Med. Virol. 58:44-48.
37. Smith, D. B., S. Pathirana, F. Davidson, E. Lawlor, P. L. Yap, and P. Simmonds. 1997. The origin of hepatitis C genotypes. J. Gen. Virol. 78:321-328.
38. Strimmer, K., and O. G. Pybus. 2001. Exploring the demographic history of DNA sequences using the generalized skyline plot. Mol. Biol. Evol. 18:2298-2305.
39. World Health Organization. 1997a. Hepatitis C. Weekly Epidemiological Record 72:65-69.
40. -. 1997b. Hepatitis C: global prevalence. Weekly Epidemiological Record 72:341-344.
41. Worobey, M. 2001. A novel approach to detecting and measuring recombination: new insights into evolution in viruses, bacteria and mitochondria. Mol. Biol. Evol. 18:1425-1434.